Next Article in Journal
Design Thinking and Urban Community Development: East Bangkok
Next Article in Special Issue
Analysis of the Steps Cycle in the Action of Throwing in Competition in Men’s Elite Handball
Previous Article in Journal
Looking for Common Ground: Marine Living Resource Development in Alaska and Northern Norway in the Context of the Blue Economy
Previous Article in Special Issue
Using Global Positioning System to Compare Training Monotony and Training Strain of Starters and Non-Starters across of Full-Season in Professional Soccer Players
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Multicomponent Exercise Training Program on Biochemical and Motor Functions in Patients with Alzheimer’s Dementia

by
Oussama Gaied Chortane
1,2,
Raouf Hammami
1,3,
Sofiene Amara
1,2,*,
Sabri Gaied Chortane
4,
Katsuhiko Suzuki
5,
Rafael Oliveira
6,7,8 and
Hadi Nobari
9,10,*
1
Higher Institute of Sport and Physical Education of Ksar-Said, Universite de La Manouba, Tunis 2010, Tunisia
2
Research Unit (UR17JS01) Sports Performance, Health & Society, Higher Institute of Sport and Physical Education of Ksar-Said, Universite de La Manouba, Tunis 2010, Tunisia
3
Research Laboratory: Education, Motor Skills, Sports and Health (LR19JS01), Higher Institute of Sport and Physical Education of Sfax, University of Sfax, Sfax 3029, Tunisia
4
Laboratory of Cardio-Circulatory, Respiratory, Metabolic and Hormonal Adaptations to Muscular Exercise, Faculty of Medicine Ibn El Jazzar, University of Sousse, Sousse 4002, Tunisia
5
Faculty of Sport Sciences, Waseda University, Saitama 359-1192, Japan
6
Sports Science School of Rio Maior, Polytechnic Institute of Santarém, 2040-413 Rio Maior, Portugal
7
Research Center in Sport Sciences, Health Sciences and Human Development, 5001-801 Vila Real, Portugal
8
Life Quality Research Centre, 2040-413 Rio Maior, Portugal
9
Department of Physiology, Faculty of Sport Sciences, University of Extremadura, 10003 Cáceres, Spain
10
Department of Exercise Physiology, Faculty of Educational Sciences and Psychology, University of Mohaghegh Ardabili, Ardabil 56199-11367, Iran
*
Authors to whom correspondence should be addressed.
Sustainability 2022, 14(7), 4112; https://0-doi-org.brum.beds.ac.uk/10.3390/su14074112
Submission received: 28 January 2022 / Revised: 22 March 2022 / Accepted: 28 March 2022 / Published: 30 March 2022

Abstract

:
The aim of this study was to examine the effects of a multicomponent exercise training program on motor function and biochemical markers in patients with Alzheimer’s-type dementia. Twenty patients with Alzheimer disease, divided into the intervention group (IG; aged 84 ± 3.1 years) and the control group (CG; aged 86 ± 2.6 years) were included in this study. The intervention group was enrolled into an exercise training program for three months (two sessions of 60 min per week). The CG was instructed to follow their daily rhythm of life (e.g., rest, reading) without a physical training program. After 3 months of participation in a multicomponent exercise program, gait speed, balance and walking parameters were all improved in the intervention group as measured with the Berg Balance Scale, the Tinetti test, the 6-min walking test and the timed up and go test (p < 0.05 for all; percentage range of improvements: 3.17% to 53.40%), except the walking while talking test, and biochemical parameters were not affected (p > 0.05). Our results demonstrate that exercise improves postural control, aerobic capacity and mobility functions in patients with Alzheimer disease. Physical exercise is a safe and effective method for treating physical disorders in patients with Alzheimer’s disease and can easily be integrated in various programs for the management of Alzheimer disease.

1. Introduction

Alzheimer disease is a progressive neurodegenerative disorder that accounts for the major cause in dementia worldwide [1]. Genetic and environmental factors contribute to the development of the disease, which is progressive and irreversible and results in cognitive and motor functions impairments [2]. The number of disease cases is expected to reach 106.8 million worldwide by the year 2050 [3]; the progression of this alarming number can be explained by the fact that the main risk factor for this neurodegenerative disease is age [4]. Currently, there is no definitive cure for Alzheimer disease; researchers in this specific area are exploring preventive therapeutic strategies that could control the progression of the disease [5]. During the last 10 years, it has been reported that physical activity has a beneficial impact and constitutes an effective solution for neurodegenerative diseases such as Alzheimer disease [6]. Prevention of Alzheimer disease can be pharmacological, non-pharmacological or a combination of both. At present, medications such as cholinesterase inhibitors and memantine produce limited benefits and do not convincingly reduce Alzheimer severity by retarding cognitive and functional decline [7]. Therefore, interest in non-pharmacological treatments for combating Alzheimer disease is increasing [8,9]. Thus, a great amount of effort and research have been undertaken to understand the physiology of the aging brain, which is changed by the type of physical activity [10]. A potent non-pharmacological treatment is physical activity, which is both known to improve cognitive function and reduce risk of cognitive decline and dementia [11]. Physical exercise is a powerful instrument used to limit the physical and functional impairments in patients with Alzheimer disease [12]. Recent studies have emphasized the impact of physical inactivity on the increased risk of developing neurodegenerative disease [13] and most particularly Alzheimer’s disease [14]. According to the American College of Sports Medicine (ACSM) [15], physical exercise contributes to reducing and to delaying the progression of chronic disease, including those associated with the aging process and related to cognitive and motor disorders. However, several studies reported the beneficial impacts of exercise as a preventive measure against Alzheimer’s disease [16].
Physical exercise interventions have been shown to be beneficial in patients with cognitive disorders [17] and delay the progress of the chronic disease [18]. At present, we know that physical exercise decreases the gravity of cognitive impairments in older patients with Alzheimer’s disease [19] and has many beneficial effects, improving physical condition, increasing autonomy and improving life quality in patients with neurodegenerative disease [20]. Research findings show evidence for different factors, such as type of exercise, frequency, intensity, time and the total duration of intervention follow-up [18]. In addition, pharmacological treatments fail to examine the cause of Alzheimer disease, and only a few symptomatic treatments are available with side effects such as weight loss and nausea [21]. Physical exercise has shown more positive results concerning chronic disease conditions [22]. For people with Alzheimer’s disease, there are several benefits for traditional cardiovascular risk factors, such as the reduced vascular flow and diabetes, which are involved in the pathogenesis of this disease [19]. It is quite important that patients maintain a physical training program for a prolonged period to obtain more beneficial effects [23]; even a minimal level of exercise (e.g., walking) generates some health benefits, as opposed to being sedentary [24].
The cognitive benefits of physical activity in patients with Alzheimer disease have been widely examined [25,26], with physical activity exerting a beneficial neuroprotective impact, reducing the incidence of mild cognitive impairment and delaying the onset of dementia [27]. Furthermore, physical activity at midlife appears to exert a neuroprotective effect later in life. For example, physical activity twice a week appears to reduce the prevalence of dementia and Alzheimer by half, two decades later [28,29]. In additional to neuroprotection, physical activity could improve functional ability in people with Alzheimer disease. For example, a physical exercise program (30 min of moderate-intensity exercise per day) has been demonstrated to improve the physical and emotional health of patients with Alzheimer [30]. Moreover, Kemoun et al. [31] confirmed the beneficial effect of exercise on physical and cognitive abilities by reporting improved cognitive function and walking speed in people with Alzheimer after 19 weeks of exercise.
The biochemical benefit of exercise in disease states is widely researched. This includes reduced oxidative stress in obese patients [32], improved glucose homeostasis in diabetes mellitus [33] and reduced low-grade inflammation in coronary artery disease [10]. Most research on patients with Alzheimer disease understandably concerns the influence of exercise on neurotrophic biomarkers.
For example, exercise alters beta-amyloid pathology in a rodent model of Alzheimer [34,35]. Moreover, the brain-derived neurotrophic factor, which ensures growth and survival of neurons, is increased following exercise training in mice [36].
However, there is a paucity of data concerning the biochemical effect of physical activity on biomarkers related to lipid profile, glucose homeostasis and organ function in Alzheimer patients. As such, more data are required from randomized controlled trials in humans to understand the biochemical and functional ability effects of exercise in Alzheimer patients. Therefore, the primary objective of this investigation was to examine the effect of exercise training on balance, walking speed and postural stability in elderly patients with dementia. Furthermore, changes in biomarkers associated with lipid profile, renal function and liver function were assessed. We hypothesized that an exercise training program would be an effective treatment for patients with Alzheimer’s disease.

2. Materials and Methods

2.1. Participants

Twenty elderly participants were recruited (aged 85 ± 3 years, with a body mass index of 26.3 ± 1.5 kg/m2 and an average Mini-Mental State Examination [MMSE] score of 19.38 ± 1.20). Most were female (n = 14); 7 drank alcohol, 6 were smokers and 18 presented comorbidities (Table 1). Subjects were informed about the experimental procedure and subsequently signed a written consent form according to the standards of the Committee for Protection of Persons of the University of Monastir (Tunisia). Patients were diagnosed with Alzheimer disease according to the International Working Group diagnosis criteria (IGW) [37] at the Neurology department of Monastir Hospital. We only recruited patients with early and moderate-stage Alzheimer disease (Clinical Dementia Rating (CDR) of 0.5 or 1 (very mild to mild dementia), who had the full capacity to consent [38].
The following criteria for inclusion were: Mini-Mental State Examination [MMSE] [39] score between 12 and 20; aged 65 or older; having normal or corrected-to-normal vision and colour perception; no drug treatment during the training protocol; living in medical care environment; and able to walk without technical assistance. None of the participants were excluded from the study due to reporting an MMSE score below 12 (indicating severe dementia and impairment); this test was used to examine the degree of cognitive level before starting the physical training program. Patients with clinically relevant medical conditions, e.g., heart disease, hypertension or diabetes or a medication that could influence cognitive functioning (e.g., benzodiazepines, sleep aids, neuroleptics) were excluded from study participation.
Eligible participants were randomly allocated to two groups. The first group of nine patients served as the control whilst the second group of eleven patients underwent physical training for three months, twice per week (60 min per session). Both groups underwent the same five tests in the morning, pre- and post-intervention period.

2.2. Mini-Mental State Examination (MMSE)

The MMSE is the most widely used brief screening measure for dementia [39]. Administration takes 5–10 min, and the following domains are evaluated: concentration or working memory; language and praxis; orientation; memory; and attention span. A total of 30 points is possible, and a score below 24 was originally identified as a threshold for cognitive impairment during validation of MMSE. A score <24 is generally considered a threshold for “mild dementia”, 19–24 indicate “moderate dementia” and 10–18 indicate “severe dementia” <10 [39].

2.3. Tinetti Test

The Tinetti balance subscale [40], which has demonstrated reasonable reliability and validity [41], involves rating individuals on 13 common tasks. It is a tool to assess abnormalities in balance and the gait of elderly subjects in various situations of everyday life [42]. The total possible score is 16, with higher scores indicating better performance.

2.4. The Berg Balance Scale

The Berg Balance Scale is the best-known balance measurement tool that accesses balance and functional activities, such as reaching, transferring, bending and standing in patients with physical and motor impairments. It consists of qualitative measures in postural control capacity: sitting and transferring oneself safely between two chairs; standing with one foot apart, two feet together, in single-leg stance and feet in the tandem Romberg position with both with eyes open and closed; standing and reaching down to pick up an object from the floor. Each item is scored according to a 5-point scale, ranging from 0 to 4 (in which 0 indicates the lowest level of function and 4 indicates the highest level of function). The total possible score is 56 points, and 41–56 suggests a low fall risk, 21–40 a medium fall risk and 0–20 a high fall risk. A change of 8 points between two assessments indicates a clinically meaningful change in function [42].

2.5. Six-Minute Walking Test (6MWT)

The six-minute walk test has been used to evaluate aerobic capacity in functional exercise performance [43]. It is a safe, simple and easy diagnostic test for evaluating motor capacity [44] in older patients [45] with cognitive and intellectual disorders [46]. This test consists of measuring the greatest possible distance that a subject can travel on a flat surface in 6 min without running. The participant walks at a comfortable rhythm for 30 m across a covered, flat, rectilinear distance, which is well-defined and not frequented. It is marked every 3 m, and two cones mark the place of U-turns. A coloured band is used to mark the starting line. This test has been widely used for measuring functional parameters in older patients [47].

2.6. Timed up and Go Test

The timed up and go test is a test that quantitatively assesses mobility and static and dynamic balance. A chair with armrests, a stopwatch/wristwatch and a tape to mark 3 m are needed for the measurement, which represents the time taken to rise from the chair, walk 3 m, turn around, walk back and sit down. A value of >14 s indicates a high fall risk [48].

2.7. The Walking and Talking Test (WTT)

This test involves the so-called dual-task paradigm, and it is a strong predictor of fall risk. Patients start walking on a computerized mat surface while reciting alternate letters of the alphabet in two different conditions. Subjects are then asked by the tester to concentrate and pay attention in both walking and talking tasks. Then, patients are asked to recite alternate letters and not to focus on the walk. Participants perform two trials, each under a different condition. Patients may slow down during the test execution if they need to stop and think about the next letter. Patients may start walking again as soon as they can. No encouragement for the patients was given, and testers intervened only in urgent situations. In the case of the latter, the trial was not recorded, and patients started a new one. Letters varied randomly between “A” (A-C-E) and “B” (B-D-F) between each trial. To reduce and limit the learning impact, patients were given more practice trials as required for both the single and dual-task conditions to familiarize themselves with the procedure of the test. The tester recorded the total number of alternate letters correctly recited in sequence and the total number of errors for 2 trials during each condition. If subjects made an error but continued accurately, the total number of alternate letters correctly recited was counted [49].

2.8. Blood Analysis and Biomechanical Assays

All blood samples were collected between 09 h:00 and 11 h:00. Following an overnight fast, participants rested in a seated position for 15 min to measure blood pressure (Omron Model HEM-737AC, Omron Healthcare, Inc., Vernon Hills, IL, USA) [50]. Five minutes later, the resting blood sample (10 mL) was collected in serum separator tubes. Samples clotted before being centrifuged at 4000 rpm for 20 min at 4 °C and were then analyzed with an automated analyzer (KBio 2 Kitvia, Labarthe-Inard, France) operating on the principle of liquid chemistry to measure NFS parameters. Lipid profile (triglycerides and cholesterol), renal function (creatinine), liver function (alanine aminotransferase [ALT]), aspartate aminotransferase (AST), alkaline phosphatase and total bilirubin, urea, calcium (Ca), glucose, potassium (K) and sodium (Na) were quantified in duplicate.

2.9. Multicomponent Exercise Training Program

The posture–balance–motility (PBM) program is an animation tool for people with a loss of autonomy. It has the objective of improving the quality of life through a bio–psycho–social approach based on adapted and individualized physical activity as a support for mobilizing the skills of the elderly person [51]. This program consists of three types of exercises: mobility, posture and balance. In the present investigation, the posture–balance–mobility program ran for 3 months (12 weeks) with two sessions per week of one hour each: 10 min of warm-up (walking on a treadmill at 3 km/h−1), 20 min of walking, muscle building and joint movement, 20 min of balance and posture training and 10 min of stretching. The first main 20 min was based on walking exercises to improve postural parameters with motor athletic parkour with 30 m of walking distance; the parkour was composed of three lines 10 m apart, indicated with six differently coloured cones: two red cones indicated the first 10 m, two blue cones were used for the second line and two yellow cones for the final line. Participants were encouraged to walk the entire distance of the three lines, touching the two cones of each line. The second main 20 min was based on mini golf exercises, in which participants practiced static and dynamic balance exercises with low-to-moderate intensity. We encouraged caregivers to play with their patients sometimes, and this was helpful and motivational. Before starting the exercises, 20 min were needed to make sure that the patients were in a resting position and dressed in comfortable clothes. The presence of relative partners or caregivers is essential to assist and support patients during all the activities.

2.10. Statistical Analysis

Data were visually inspected for potential outliers, and normality was checked using the Shapiro–Wilk test due to the small sample size. Based on the normal distribution, parametric tests were used. Chi-squared test, Student’s t-test and repeated-measures analysis of variance (ANOVA) with Bonferroni’s post hoc test were conducted to test for an effect of group (control and intervention) and time (pre- and post-training). The reliability of the variables in this study was determined using Cronbach’s alpha. All statistical analyses were carried out using the commercial software Statistical package for social sciences (SPSS version 23.0, IBM, Chicago, IL, USA). The alpha level was set a priori at p < 0.05.

3. Results

3.1. Change in Physical Function

Table 2 presents the comparison within and between groups at baseline and post-intervention for all performance parameters.
At baseline, there were no differences between groups. In addition, the intervention group improved in most of the physical tests after 3 months of participating in the physical activity program. However, after training, the exercise group achieved a significantly better performance in balance and postural capacity. For the Tinetti test (TT), there was an effect of group, time and interaction (p < 0.001); patients were able to realize all the 13 subtests, and they achieved a better performance in TT than the control group (IG = 53.4%; CG = 7.2%). The interrater reliability values of the Tinetti test’s Cronbach alpha were 0.97 (0.94–0.98) and 0.94 (0.90–0.97) for both balance and gait subscales (Figure 1).
In the 6MWT, patients in the exercise group walked a longer distance in comparison with the baseline measure, a significant improvement in walking distance with less stability disorders and time (p < 0.001), and the interaction (group × time; p = 0.008) reached significance, where the intervention group improved more than the control group IG = 52.5%; CG = 30.1% (Figure 2).
Performance in the Berg Balance Scale improved significantly after the intervention protocol (p = 0.001). The improvements of the score in static and dynamic balance abilities in patients with Alzheimer’s disease with a better result in the intervention group were IG = 3.17%; CG = 2.8%. The interrater reliability values of the balance scale score with global ratings of the patients ranged from 0.47 to 0.51 and from 0.39 to 0.45. The coefficients were moderate and statically significant (Figure 3).
A beneficial impact of physical exercise was seen in the intervention group with significant results in the timed up and go test; the time between starting and ending the test was improved, and the interaction group × training was significant (p = 0.001), whereby the intervention group improved more than the control group, who performed worse in the test (IG = 14.5%; CG = 7.11%) (Figure 4).
After the intervention period, our results show a significant improvement in most of the physical tests, except the WTT (Figure 5); patients had many difficulties in realizing the dual-tasks performance test, and there was no significant effect of group, time or interaction (all, p > 0.05).

3.2. Effect of Physical Activity on Biochemical Parameters

At baseline, the intervention group had a greater BMI (p = 0.003) and lower creatinine (p = 0.003) triglycerides (p < 0.001), Ca, (p = 0.011) and K (p = 0.036) than the intervention group. As shown in Table 1 and Table 3, there was no effect of training on biochemical parameters (p > 0.05).

4. Discussion

The objective of this study was to investigate the effects of a three-month multicomponent training program on physical functions and biochemical parameters in older patients with Alzheimer disease. We adopted a simple and comprehensive protocol to identify the effects of PA on motor and biochemical functions. In addition, we objectively assessed various physical tests that can be easily performed with minimal equipment. However, as performance on these tests requires the patients to understand the instructions and be motivated to complete the tests, the results in part fulfilled our expectation; the individuals with Alzheimer disease who participated in the exercise program presented improvement in walking parameters with better mobility and postural capacity, which confirm the importance of this type of non-pharmacological treatment for older patients with Alzheimer disease.

4.1. Intervention

Alzheimer’s is generally considered as a disease mainly affecting both cognitive and motor function. Van Doorn et al. [52] drew attention to the fact that Alzheimer patients are twice as likely to fall as healthy aged persons. Physical disorders generally take place while the subject is walking, which is to say over the course of a dynamic activity. The physical program that we applied in this study proved to be a safe intervention in relation to the objectives fixed from the beginning of this study. We considered the beneficial effects of physical exercise on risk factors for falls and fractures, such as cognitive decline, loss, gait and balance, as well as the positive effects on quality of life and autonomy for AD patients, as stated in some previous studies [53]. In addition, we conducted a group intervention to enhance the beneficial effects of collective work, although with a small number of participants [54] to provide individualized attention according to the needs of each patient. Despite the American College of Sports Medicine and some other studies providing evidence of the beneficial impacts of unsupervised physical activity [55], other studies reported a better effect produced by systematized and supervised physical exercise [56].

4.2. Effects of Physical Activity on Functional Parameters

To examine the impact of the intervention on physical functions, balance and gait disturbances were evaluated as risk factors in older patients with Alzheimer’s. Some of the most commonly used tests in elderly people and Alzheimer’s patients were used for this purpose. However, the variety of parameters around the interventions and assessment tools used in the previous studies complicates comparisons. A scientific and clinical consensus on these aspects is required. As for our study, it shows a positive impact of physical exercises on mobility and balance efficiency in our patients, which may consequently decrease the risk of physical functions, as was shown by Toulotte et al. [57]. Regarding the time up and go test, gait and balance were improved in AD patients following 12 weeks of a multicomponent training program by (14.50%), a more significant test result compared with other studies. De Andrade et al. [58] and Yao et al. [59] reported a decreasing of about two seconds with a four-month intervention, an improvement that we obtained in the first month, which was maintained. We also saw improvement in the Tinetti test (53.40%), Berg Balance Scale (3.17%) and the walking and talking test (115%). As such, exercises should focus on improving gait and dynamic balance during voluntary movements as well as during unpredictable disturbances [60]. To ensure the effectiveness of training, balance and walking should be trained with verbal instructions as a basic element [61]. Gras et al. [62] recruited a sample of 13 mild-AD adults (~73 years old) matched with 13 subjects without AD. Participants with mild AD had significantly shorter times in the sharpened Romberg tests with eyes open and closed compared to the controls.
Results concerning the 6-min walking test show a significant improvement in walking distance concerning the intervention group (52.50%); the finding of this result is in line with other published data [63]. Improvements in functional performances, such as a better walking ability, was observed after the physical program in older patients with Alzheimer disease [64]. Various types of exercise improve walking parameters such as gait speed [65], double support time [66] and stride length [67]. Our exercise program significantly increased the mean score of the Tinetti test in patients of the intervention group; this finding of improvement is in agreement with the study of Santana-Sosa et al. [68], who found that a multicomponent training program improved the score of the Tinetti test and the time up and go tests, two simple and very acceptable tests used to examine the impact of physical activity on physical function [69].
The association among physical activity, walking and balance capacities in older patients has already been examined. According to Rolland et al. [70], significantly heightened walking speed has been observed after 6 months of walking for 12 months with supervision. Leisure time spent engaging in physical activity seems to be particularly protective against AD, even though, given the low-to-moderate quality of studies, current evidence does not permit specific practical recommendations in terms of type, frequency, intensity or duration of PA. Three months of a physical activity program with multiple types of mobility, gait and balance exercises improved physical functions in older patients. As participants already suffer from decreasing muscle mass and strength, balance training has been shown to improve physical capacity and postural ability.

4.3. Effects of Physical Activity on Biochemical Parameters

It is known that physical exercise reduces cardiovascular disorders by increasing the level of high-density lipids (HDL) in the blood [71], reduces low-grade inflammation in coronary artery pathology [72] and may change biochemical biomarkers, but unfortunately, in our results, we did not find an association between physical activity and biochemical parameters. Research on this aspect is still needed to examine if there is a relationship between physical activity and biochemical biomarkers in AD patients [73].

4.4. Limitation

Some limitations of the present study should be noted. First, this study is based on a randomized control study with a small size of patients from both genders. Future studies are needed to determine the benefits of physical activity programs with a larger sample size of elderly patients for both genders. Second, an examination of the effect of physical activity programs on functional parameters with both objective and subjective measures is needed to clarify the positive impact of physical programs on a patient’s well-being. Futures studies should quantitatively and qualitatively compare the effects of different types of PE on a patient’s life quality. Researchers and health-care workers should pay attention to exercise program adherence in this elderly population.

5. Conclusions

In recent years, numerous studies have indicated many beneficial effects of physical exercise on the physical health of aged patients. However, exercise is increasingly being considered as a standard of care for preventing cognitive and physical disorders. Accordingly, the exercise regimens should be individually tailored to ensure better benefits for all patients [74]. The present study showed that physical exercise programs optimize functional parameters for Alzheimer’s patients. The 12 weeks of the multicomponent training program induced positive changes in postural control, walking and mobility functions, especially for the intervention group, who obtained a better result compared with the control group, who had a small improvement. Physical activity can be beneficial in all stages of Alzheimer disease. However, to obtain more insight into the mechanism underlying the impacts of physical activity, we need more high-quality studies. It is of the utmost importance that specific information about the intervention is well-documented, such as the characteristics of the patients and the duration, intensity and different components of the intervention program. This information is important in order to interpret the external validity, possible confounders and the dose–response relationship among physical activity, functional and biochemical parameters.

Author Contributions

Conceptualization, O.G.C., H.N. and S.A.; formal analysis, S.G.C. and R.O.; methodology, S.A. and S.G.C.; writing—original draft, O.G.C., H.N., R.O., K.S. and S.A.; and writing—review and editing, R.H., H.N., R.O., K.S., O.G.C. and S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the ethical advisory committee of the Research Unit (UR17JS01) Sports Performance, Health and Society, Higher Institute of Sport and Physical Education of Ksar Saîd, University of Manouba, Tunis, 2010, Tunisia. Additionally, all procedures performed in studies involving human participants were in accordance with the ethical standards. The study protocol was accepted by the Ethical Commission of CHU Monastir (Ref. TN02196546, April 2018).

Informed Consent Statement

Informed consent was obtained from all subjects and guardians involved in the study.

Data Availability Statement

The data presented in this study are available on reasonable request from R.H.

Acknowledgments

The authors thank all the subjects who participated in this study, and all individuals included in this section have consented to this acknowledgement.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blennow, K.; Leon, M.J.; Zetterberg, H. Alzheimer’s disease. Lancet 2006, 368, 387–403. [Google Scholar] [CrossRef]
  2. Paulson, H.L.; Igo, I. Genetics of dementia. Semin. Neurol. 2011, 31, 449–460. [Google Scholar] [CrossRef] [PubMed]
  3. Brookmeyer, R.; Johnson, E.; Ziegler-Graham, K.; Arrighi, H.M. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007, 3, 186–191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. World Health Organization. Global Health and Aging. 2019. Available online: https://www.who.int/ageing/publications/global_health.pdf (accessed on 27 January 2022).
  5. Emery, V.O. Alzheimer disease. Are we intervening too late. Pro. J. Neural. Transm. 2011, 118, 1361–1378. [Google Scholar] [CrossRef] [PubMed]
  6. Nobari, H.; Azimzadeh, E.; Hassanlouei, H.; Badicu, G.; Pérez-Gómez, J.; Ardigò, L.P. Effect of Physical Guidance on Learning a Tracking Task in Children with Cerebral Palsy. Int. J. Environ. Res. Public Health 2021, 18, 7136. [Google Scholar] [CrossRef]
  7. Matsunga, S.; Kishi, T.; Iwata, N. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer’s disease: A systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 2014, 18, 115. [Google Scholar] [CrossRef]
  8. Buschert, V.; Bokde, L.W.; Hampel, H. Cognitive intervention in Alzheimer disease. Nat. Rev. Neurol. 2010, 6, 508–517. [Google Scholar] [CrossRef]
  9. Reijnders, J.; van Heugten, C.; van Boxtel, M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: A systematic review. Ageing. Res. Rev. 2013, 12, 263–275. [Google Scholar] [CrossRef]
  10. Nobari, H.; Ahmadi, M.; Sá, M.; Pérez-Gómez, J.; Clemente, F.M.; Adsuar, J.C.; Minasian, V.; Afonso, J. The effect of two types of combined training on bio-motor ability adaptations in sedentary females. J. Sports Med. Phys. Fit. 2021, 61, 1317–1325. [Google Scholar] [CrossRef]
  11. Nobari, H.; Rezaei, S.; Sheikh, M.; Fuentes-García, J.P.; Pérez-Gómez, J. Effect of Virtual Reality Exercises on the Cognitive Status and Dual Motor Task Performance of the Aging Population. Int. J. Environ. Res. Public Health 2021, 18, 8005. [Google Scholar] [CrossRef] [PubMed]
  12. Pitkälä, K.H.; Pöysti, M.M.; Laakkonen, M.L.; Tilvis, R.S.; Savikko, N.; Kauti¬ainen, H. Effects of the Finnish Alzheimer disease exercise trial (FINALEX): A randomized controlled trial. JAMA. Intern. Med. 2013, 173, 894–901. [Google Scholar] [CrossRef] [PubMed]
  13. Sallis, J.F.; Bull, F.; Guthold, R. Physical activity: Progress and challenges. Progress in physical activity over the Olympic quadrennium. Lancet 2016, 388, 1325–1336. [Google Scholar] [CrossRef]
  14. Norton, S.; Matthews, F.E.; Barnes, D.E.; Yaffe, K.; Brayne, C. Potential for primary prevention of Alzheimer’s disease: An analysis of population based data. Lancet Neurol. 2014, 13, 788–794. [Google Scholar] [CrossRef] [Green Version]
  15. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription; American College of Sports Medicine: Indianapolis, IN, USA, 2014. [Google Scholar]
  16. Radak, Z.; Hart, N.; Sarga, L. Exercice plays a preventive role against Alzheimer’s disease. J. Alzheimers Dis. 2010, 20, 777–783. [Google Scholar] [CrossRef] [Green Version]
  17. Allali, G.; Verghese, J. Management of gait changes and fall risk in MCI and dementia. Curr. Treat. Options Neurol. 2017, 19, 29. [Google Scholar] [CrossRef] [PubMed]
  18. Jia, R.X.; Liang, J.H.; Xu, Y. Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: A meta-analysis. BMC Geriatr. 2019, 19, 181. [Google Scholar] [CrossRef]
  19. Valenzuela, P.L.; Castillo-García, A.; Morales, J.S.; de la Villa, P.; Hampel, H.; Emanuele, E.; Lista, S.; Lucia, A. Exercise benefits on Alzheimer’s disease: State-of-the-science. Ageing Res. Rev. 2020, 62, 101108. [Google Scholar] [CrossRef]
  20. Shams, A.; Nobari, H.; Afonso, J.; Abbasi, H.; Mainer-Pardos, E.; Pérez-Gómez, J.; Bayati, M.; Bahrami, A.; Carneiro, L. Effect of Aerobic-Based Exercise on Psychological Well-Being and Quality of Life Among Older People: A Middle East Study. Front. Public Health 2021, 9, 764044. [Google Scholar] [CrossRef]
  21. McGurran, H.; Glenn, J.M.; Madero, E.N. Prevention and treatment of Alzheimer’s disease: Biological mechanisms of exercise. J. Alzheimers Dis. 2019, 69, 311–338. [Google Scholar] [CrossRef]
  22. Fiuza-Luces, C.; Garatachea, N.; Berger, N.A. Exercise is the real polyplill. Physiology 2013, 28, 330–358. [Google Scholar] [CrossRef] [Green Version]
  23. Lox, C.L.; Ginis, K.A.; Petruzzello, S.J. The Psychology of Exercise: Integrating Theory and Practice; Taylor & Francis: Abingdon, UK, 2016; Available online: https://www.amazon.com/Psychology-Exercise-Integrating-Theory-Practice/dp/1621590062 (accessed on 27 January 2022).
  24. Gibson-Moore, H. UK Chief Medical Officers’ physical activity guidelines. What’s new and how can we get people more active? Nutr. Bull. 2019, 44, 320–328. [Google Scholar] [CrossRef]
  25. Blondell, S.J.; Hammersley-Mather, R.; Veerman, J.L. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014, 14, 510. [Google Scholar] [CrossRef] [Green Version]
  26. Sofi, F.; Valecchi, D.; Bacci, D.; Abbate, R.; Gensini, G.; Casini, A. Physical activity and risk of cognitive decline: A meta-analysis of prospective studies. J. Intern. Med. 2011, 269, 107–117. [Google Scholar] [CrossRef]
  27. Teri, L.; Gibbons, L.E.; McCurry, S.M. Exercise plus behavioral management in patients with Alzheimer disease: A randomized controlled trial. JAMA 2013, 290, 2015–2022. [Google Scholar] [CrossRef]
  28. Paillard, T.; Rolland, Y.; de Souto Barreto, P. Protective effects of physical exercise in Alzheimer’s disease and Parkinson’s disease: A narrative review. J. Clin. Neurol 2015, 11, 212–219. [Google Scholar] [CrossRef] [Green Version]
  29. Sinaei, M.; Alaei, H.; Nazem, F.; Kargarfard, M.; Feizi, A.; Talebi, A.; Esmaeili, A.; Nobari, H.; Pérez-Gómez, J. Endurance exercise improves avoidance learning and spatial memory, through changes in genes of GABA and relaxin-3, in rats. Biochem. Biophys. Res. Commun. 2021, 566, 204–210. [Google Scholar] [CrossRef]
  30. Rovio, S.; Kareholt, I.; Viitanen, M.; Winblad, B.; Tuomilehto, J.; Soininen, H. Work-related physical activity and the risk of dementia and Alzheimer’s disease. Int. J. Psychiatry 2007, 22, 874–882. [Google Scholar] [CrossRef]
  31. Kemoun, G.; Thibaud, M.; Roumagne, N.; Carette, P.; Albinet, C.; Toussaint, L. Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dement. Geriatr. Cogn. Disord. 2010, 29, 109–114. [Google Scholar] [CrossRef]
  32. Krause, M.; Rodrigues-Krause, J.; O’Hagan, C.; Medlow, P.; Davison, G.; Susta, D. The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: Implications for oxidative stress, low-grade inflammation and nitric oxide production. Eur. J. Appl. Physiol. 2014, 114, 251–260. [Google Scholar] [CrossRef] [Green Version]
  33. Hamman, R.F.; Wing, R.R.; Edelstein, S.L.; Lachin, J.M.; Bray, G.A.; Delahanty, L. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006, 26, 2102–2107. [Google Scholar] [CrossRef] [Green Version]
  34. Adlard, P.A.; Perreau, V.M.; Pop, V.; Cotman, C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J. Neurosci. 2005, 25, 4217–4221. [Google Scholar] [CrossRef]
  35. Kim, B.K.; Shin, M.S.; Kim, C.J.; Baek, S.B.; Ko, Y.C.; Kim, Y.P. Treadmill exercise improves short-term memory by enhancing neurogenesis in amyloid beta-induced Alzheimer disease rats. J. Exerc. Rehabil. 2014, 10, 2–8. [Google Scholar] [CrossRef]
  36. Um, H.; Kang, E.; Leem, Y.; Cho, I.; Yang, C.; Chae, K. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer’s disease in an NSE/APP-transgenic model. Int. J. Mol. 2008, 4, 529–539. [Google Scholar]
  37. Guyatt, G.H.; Pugsley, S.O.; Sullivan, M.J.; Thompson, P.J.; Berman, L.; Jones, N.L.; Fallen, E.L.; Taylor, D.W. Effect of encouragement on walking test performance. Thorax 1984, 93, 812–822. [Google Scholar] [CrossRef] [Green Version]
  38. Morris, J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993, 43, 2412b-4. [Google Scholar] [CrossRef]
  39. Folstein, M.F.; Folstein, S.E.; McHugh, P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr Res. 1975, 12, 189–198. [Google Scholar] [CrossRef]
  40. Tinetti, M.E.; Williams, T.F.; Mayewski, R. Fall risk index for elderly patients based on number of chronic disabilities. Am. J. Med. 1986, 80, 429–434. [Google Scholar] [CrossRef]
  41. Canbek, J.; Fulk, G.; Nof, L.; Echternach, J. Test-retest reliability and construct validity of the Tinetti performance-oriented mobility assessment in people with stroke. J. Neurol. Phys. Ther. 2013, 37, 14–19. [Google Scholar] [CrossRef]
  42. Berg, K.; Wood-Dauphinee, S.; Williams, J.I.; Maki, B. Measuring balance in the elderly: Validation of an instrument. Can. J. Pub. Health 1992, 2, S7–S11. [Google Scholar]
  43. Enright, P.L.; Sherrill, D.L. Reference equations for the six-minute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998, 158, 1384–1387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Troosters, T.; Gosselink, R.; Decramer, M. Six minute walking distance. Eur. Respir. J. 1999, 14, 270–274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Stiliwell, K.M.; Forman, D.E.; McElwain, D.; Simpson, C.; Garber, C.E. The 6 minutes walk test for evaluation of functional capacity in elderly adults. Med. Sci. Sport Exerc. 1996, 28, S152. [Google Scholar] [CrossRef]
  46. Guerra-Balic, M.; Oviedo, G.R.; Javierre, C.; Fortuño, J.; Barnet-López, S.; Niño, O. Reliability and validity of the 6-min walk test in adults and seniors with intellectual disabilities. Res. Dev. Disabil. 2015, 47, 144–153. [Google Scholar] [CrossRef]
  47. Lord, S.R.; Menz, H.B. Physiologic, psychologic, and health predictors of 6-minute walk performance in older people. Arch. Phys. Med. Rehabil. 2002, 83, 907–911. [Google Scholar] [CrossRef]
  48. Podsiadlo, D.; Richardson, S. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons. J. Am. Geriatr. Soc. 1991, 39, 142–148. [Google Scholar]
  49. Verghese, J.; Kuslansky, G.; Holtzer, R.; Katz, M.; Xue, X.N.; Buschke, H. Walking while talking: Effect of task prioritization in the elderly. Arch. Phys. Med. Rehabil. 2007, 88, 50–53. [Google Scholar] [CrossRef] [Green Version]
  50. Anwar, Y.A.; Giacco, S.; McCabe, E.J.; Tendler, B.E.; White, W.B. Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press. Monit. 1998, 3, 261–265. [Google Scholar]
  51. Albinet, C.; Bernard, P.L.; Palut, Y. Attentional control of postural stability in institutionalised elderly people: Effects of a physical exercise program. Ann. Readapt. Med. Phys. 2006, 9, 625–631. [Google Scholar] [CrossRef]
  52. Van Doorn, C.; Gruber-Baldini, A.L.; Zimmerman, S.; Hebel, J.R.; Port, C.; Baumgarten, M.; Quinn, C.C.; Taler, G.; May, C.; Magaziner, J. Epidemiology of Dementia in Nursing Home Research Group: Dementia as a risk factor for falls and fall injuries among nursing home residents. J. Am. Geriatr. Soc. 2003, 51, 1213–1218. [Google Scholar] [CrossRef]
  53. Li, X.; Guo, R.; Wei, Z.; Jia, J.; Wei, C. Effectiveness of Exercise Programs on Patients with Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. BioMed Res. Int. 2019, 2019, 2308475. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Jensen, L.E.; Padilla, R. Effectiveness of interventions to prevent falls in people with Alzheimer’s disease and related dementias. Am. J. Occup. Ther. 2011, 65, 532–540. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Nelson, M.E.; Rejeski, W.J.; Blair, S.N.; Duncan, P.W.; Judge, J.O. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116, 1094–1105. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Manckoundia, P.; Taroux, M.; Kubicki, A.; Mourey, F. Impact of ambulatory physiotherapy on motor abilities of elderly subjects with Alzheimer’s disease. Geriatr. Gerontol. Int. 2014, 14, 167–175. [Google Scholar] [CrossRef] [PubMed]
  57. Toulotte, C.; Thévenon, A.; Fabre, C. Effects on training on static and dynamic balance in elderly subjects who have a fall or not. Ann. Readapt. Med. Phys. 2004, 47, 604–610. [Google Scholar] [CrossRef]
  58. De Andrade, L.P.; Gobbi, L.T.; Coelho, F.G.; Christofoletti, G.; Costa, J.L.; Stella, F. Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer’s disease: A controlled trial. J. Am. Geriatr. Soc. 2013, 61, 1919–1926. [Google Scholar] [CrossRef]
  59. Yao, L.; Giordani, B.J.; Algase, D.L.; You, M.; Alexander, N.B. Fall Risk-Relevant Functional Mobility Outcomes in Dementia Following Dyadic Tai Chi Exercise. West. J. Nurs. Res. 2012, 35, 281–296. [Google Scholar] [CrossRef] [Green Version]
  60. Vitório, R.; Teixeira-Arroyo, C.; Lirani-Silva, E.; Barbieri, F.A.; Caetano, M.J.D.; Gobbi, S. Effects of 6-month, multimodal exercise program on clinical and gait parameters of patients with idiopathic Parkinson’s disease: A pilot study. ISRN Neurol. 2011, 2011, 714947. [Google Scholar] [CrossRef] [Green Version]
  61. Fasola, J.; Mataric, M.J. Using socially assistive human–robot interaction to motivate physical exercise for older adults. Proc. IEEE 2012, 100, 2512–2526. [Google Scholar] [CrossRef]
  62. Gras, L.Z.; Kanaan, S.F.; McDowd, J.M.; Colgrove, Y.M.; Burns, J.; Pohl, P.S. Balance and gait of adults with very mild Alzheimer disease. J. Geriatr. Phys. 2015, 38, 1–7. [Google Scholar] [CrossRef] [Green Version]
  63. Steffen, T.M.; Hacker, T.A.; Mollinger, L. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys. Ther. 2002, 82, 128–137. [Google Scholar] [PubMed] [Green Version]
  64. Steinberg, M.; Leoutsakos, J.S.; Podewils, L.J.; Lyketsos, C. Evaluation of home-based exercise program in the treatment of Alzheimer’s disease: The maximizing independence in dementia (MIND) study. Int. J. Geriatr. Psychiatry 2009, 24, 680–685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Doi, T.; Makizako, H.; Shimada, H.; Yoshida, D.; Tsutsumimoto, K.; Sawa, R.; Misu, S.; Suzuki, T. Effects of multicompo-nent exercise on spatial-temporal gait parameters among the elderly with amnestic mild cognitive impairment (aMCI): Preliminary results from a randomized controlled trial (RCT). Arch. Gerontol. Geriatr. 2013, 56, 104–108. [Google Scholar] [CrossRef] [PubMed]
  66. Schwenk, M.; Zieschang, T.; Oster, P.; Hauer, K. Dual-task performances can be improved in patients with dementia: A randomized controlled trial. Neurology 2010, 74, 1961–1968. [Google Scholar] [CrossRef] [PubMed]
  67. Santana-Sosa, E.; Barriopedro, M.I.; Lopez-Mojares, L.M.; Perez, M.; Lucia, A. Exercise training is beneficial for Alz-heimer’s patients. Int. J. Sports Med. 2008, 29, 845–850. [Google Scholar] [CrossRef] [PubMed]
  68. Suttanon, P.; Hill, K.D.; Said, C.M.; Williams, S.B.; Byrne, K.N.; LoGiudice, D.; Lautenschlager, N.T.; Dodd, K.J. Feasi-bility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer’s disease: A pilot randomized controlled trial. Clin. Rehabil. 2013, 27, 427–438. [Google Scholar] [CrossRef] [PubMed]
  69. Rolland, Y.; Pillard, F.; Klapouszczak, A.; Reynish, E.; Thomas, D.; Andrieu, S.; Rivière, D.; Vellas, B. Exercise program for nursing home residents with Alzheimer’s disease: A 1-year randomized, controlled trial. J. Am. Geriatr. Soc. 2007, 55, 158–165. [Google Scholar] [CrossRef]
  70. Hill, K.D.; LoGiudice, D.; Lautenschlager, N.T.; Said, C.M.; Dodd, K.J.; Sut¬tanon, P. Effectiveness of balance training exercise in people with mild to moderate severity Alzheimer’s disease: Protocol for a randomised trial. BMC Geriatr. 2009, 9, 29. [Google Scholar] [CrossRef] [Green Version]
  71. Durstine, J.L. Effect of aerobic exercise training on serum level of high density lipoprotein cholesterol. Clin. J. Sport Med. 2008, 18, 107–108. [Google Scholar] [CrossRef]
  72. Adamopoulos, S.; Schmid, J.P.; Dendale, P.; Poerschke, D.; Hansen, D.; Dritsas, A. Combined aerobic/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: The Vent-HeFT trial: A European prospective multicentre randomized trial. Eur. J. Heart Fail. 2014, 16, 574–582. [Google Scholar] [CrossRef] [Green Version]
  73. Kraus, W.E.; Houmard, J.A.; Dusha, B.D.; Knetzger, K.J.; Wharton, M.B.; McCartnet, J.S. Effect of the amount and intensi-ty of exercice on plasma lipoprotein. N. Engl. J. Med. 2002, 347, 1483–1492. [Google Scholar] [CrossRef] [PubMed]
  74. Buford, T.W.; Roberts, M.D.; Church, T.S. Toward exercise as personalized medicine. Sports Med. 2013, 43, 157–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Tinetti test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Figure 1. Tinetti test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Sustainability 14 04112 g001
Figure 2. Six-Minutes Walking test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Figure 2. Six-Minutes Walking test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Sustainability 14 04112 g002
Figure 3. Berg Balance Scale test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Figure 3. Berg Balance Scale test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Sustainability 14 04112 g003
Figure 4. Timed up and go test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Figure 4. Timed up and go test comparisons within and between groups at baseline and post-intervention. Values are means (±SD). * Significantly different (p < 0.05) for the intervention group after 12 weeks of multicomponent physical training program.
Sustainability 14 04112 g004
Figure 5. Walking and talking test comparisons within and between groups at baseline and post-intervention. Values are means (±SD).
Figure 5. Walking and talking test comparisons within and between groups at baseline and post-intervention. Values are means (±SD).
Sustainability 14 04112 g005
Table 1. Characteristics of the Alzheimer’s patients in a control and intervention group.
Table 1. Characteristics of the Alzheimer’s patients in a control and intervention group.
CharacteristicsOverall PopulationControl GroupIntervention Group
Patients (N)20911
Years84 ± 3.086 ± 2.684 ± 3.1
Body Mass Index (kg/m2)26 ± 1.525 ± 1.327 ± 1.1
Higher education level1578
Alcohol use734
Comorbidities18810
Table 2. Performance parameters in Alzheimer’s patients in a control and intervention group pre-and post-intervention.
Table 2. Performance parameters in Alzheimer’s patients in a control and intervention group pre-and post-intervention.
VariableControl GroupDelta Change (%)Intervention GroupDelta Change (%)p-Value
BeforeAfterBeforeAfterGroupTimeInteraction
Berg Balance Scale42.22 ± 2.6841.00 ± 1.73 *2.841.92 ±2.7843.25 ± 2.14 *3.170.3060.9140.021
Tinetti test12.67 ± 2.2413.56 ± 0.88 *7.0212.17 ± 1.8018.67 ± 1.07 *53.40<0.001<0.001<0.001
6-min walking test115.89 ± 9.53150.67 ± 14.38 *30.01111.00 ± 21.39169.33 ± 16.51 *52.500.273<0.0010.008
Time up and go21.78 ± 2.8223.33 ± 1.66 *7.1123.50 ± 3.4820.08 ± 1.51 *−14.500.4250.1410.001
Walking and Talking0.56 ± 0.530.56 ± 0.5300.58 ± 0.671.25 ± 0.62 *115%<0.001<0.001<0.001
* indicates a significant increase from pre- to post-test for this group with p < 0.05.
Table 3. Baseline biochemical parameters for Alzheimer’s patients in a control and intervention group.
Table 3. Baseline biochemical parameters for Alzheimer’s patients in a control and intervention group.
VariableControl GroupIntervention Groupp-Value
Red blood cell count (×109/L)3.86 ± 0.574.11 ± 0.280.196
White blood cell count (×109/L)6284.44 ± 545.856717.75 ± 552.130.090
Hemoglobin (g/dL)13.52 ± 0.9413.91 ± 0.610.262
Platelet count279.08 ± 47.79277.33 ± 28.670.918
Hematocrit (%)43.35 ± 2.6842.81 ± 2.440.635
Triglycerides (mg/dL)2.14 ± 0.3042.81 ± 2.44<0.001
Cholesterol (mg/dL)4.12 ± 0.603.76 ± 0.880.310
Total bilirubin (mg/dL)8.79 ± 0.898.76 ± 0.630.917
Aspartate transaminase (ASAT)14.44 ± 1.4214.50 ± 1.980.944
Alanine transaminase (ALAT)12.00 ± 1.1212.17 ± 1.470.780
Blood pressure (mmHg)85.44 ± 6.0484.88 ± 4.960.815
Creatinine (mg/dL)138.44 ± 4.98117.42 ± 17.730.003
Urea (mg/dL)4.61 ± 0.814.90 ± 1.130.525
Glucose (mg/dL)4.01 ± 0.883.93 ± 0.780.812
Sodium (Na) (mEq/L)140.78 ± 9.67142.50 ± 7.790.656
Calcium (Ca) (mEq/L)3.68 ± 1.102.66 ± 0.540.011 *
Potassium (K) (mEq/L)4.27 ± 1.033.42 ± 0.700.036 *
* Significantly different between groups (p < 0.05).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chortane, O.G.; Hammami, R.; Amara, S.; Chortane, S.G.; Suzuki, K.; Oliveira, R.; Nobari, H. Effects of Multicomponent Exercise Training Program on Biochemical and Motor Functions in Patients with Alzheimer’s Dementia. Sustainability 2022, 14, 4112. https://0-doi-org.brum.beds.ac.uk/10.3390/su14074112

AMA Style

Chortane OG, Hammami R, Amara S, Chortane SG, Suzuki K, Oliveira R, Nobari H. Effects of Multicomponent Exercise Training Program on Biochemical and Motor Functions in Patients with Alzheimer’s Dementia. Sustainability. 2022; 14(7):4112. https://0-doi-org.brum.beds.ac.uk/10.3390/su14074112

Chicago/Turabian Style

Chortane, Oussama Gaied, Raouf Hammami, Sofiene Amara, Sabri Gaied Chortane, Katsuhiko Suzuki, Rafael Oliveira, and Hadi Nobari. 2022. "Effects of Multicomponent Exercise Training Program on Biochemical and Motor Functions in Patients with Alzheimer’s Dementia" Sustainability 14, no. 7: 4112. https://0-doi-org.brum.beds.ac.uk/10.3390/su14074112

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop